The Role of Vitamin C Supplementation in Preventing Severity Progression in Mild and Moderate COVID-19 Patients at Universitas Airlangga Hospital
Open Access
- 10 January 2025
- journal article
- Published by Universitas Airlangga in JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
- Vol. 16 (1) , 63-69
Abstract
Highlights: The administration of different dosages of vitamin C significantly yields different outcomes in preventing the progression of disease severity. Abstract Introduction:Coronavirus disease (COVID-19) is an infectious disease that increases pro-oxidant elements and decreases antioxidants. Vitamin C functions as a potent antioxidant in humans due to its electron-donating properties. This study aimed to explain the impact of three distinct vitamin C supplementation dosages in preventing disease severity progression among mild and moderate COVID-19 patients. Methods:This retrospective study used secondary data from 100 medical records (n=100). The subjects were classified into three categories based on the vitamin C dosage. The data were analyzed using the International Business Machines Corporation (IBM) Statistical Package for Social Sciences (SPSS) version 26.0 for Windows. Results:Most of mild and moderate COVID-19 patients (78%) did not experience increased disease severity. Vitamin C supplementation significantly demonstrated a different outcome in preventing disease severity progression among the three groups (p=0.018). However, it did not significantly show any difference in reducing the duration of hospital stay (p=0.680). Conclusion:The impact of vitamin C supplementation on COVID-19 severity appeared to vary depending on the dosage administered. However, it did not affect the duration of the hospital stay.Keywords
This publication has 25 references indexed in Scilit:
- Oxidative Stress Biomarkers and Their Association with Mortality among Patients Infected with SARS‐CoV‐2 in MexicoOxidative Medicine and Cellular Longevity, 2022
- Covid-19: Cases of delta variant rise by 79%, but rate of growth slowsBMJ, 2021
- Delta variant: What is happening with transmission, hospital admissions, and restrictions?BMJ, 2021
- Covid-19: Delta variant is now UK’s most dominant strain and spreading through schoolsBMJ, 2021
- Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trialEuropean Journal of Medical Research, 2021
- Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern NigeriaSage Open Medicine, 2021
- Overview of the possible role of vitamin C in management of COVID-19Pharmacological Reports, 2020
- COVID-19 length of hospital stay: a systematic review and data synthesisBMC Medicine, 2020
- Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndromePharmaNutrition, 2020
- Discrepancies in global vitamin C recommendations: a review of RDA criteria and underlying health perspectivesCritical Reviews in Food Science and Nutrition, 2020